Empowering Providers & Patients to Battle Advanced Biliary Tract Cancers

Expert Guidance on Integrating the Latest Evidence on Immunotherapy and Targeted Agents in Real-World Practice

Live In-Person and Virtual Symposium on Thursday, January 18, 2024

• Registration & Dinner | 5:15-5:30 PM PST
• In-Person & Virtual Symposium | 5:30-7 PM PST / 6:30-11 PM AZT / 8:30-10 PM EST

REGISTER HERE!

Key Reasons to Attend

1. Learn about the latest evidence supporting the use of modern and emerging immunotherapy and targeted approaches for the management of BTC
2. Hear about guideline recommendations for developing individualized treatment regimens for patients with advanced BTC
3. Explore the use of team-based strategies to address the monitoring of patients, patient education, and AE management

This activity has been developed in partnership with the Cholangiocarcinoma Foundation.

CME/MOC/AAPA/IPCE Information

Chair & Moderator
Milind Javle, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas

Presenter
Tanios Bekaii-Saab, MD
Mayo Clinic College of Medicine and Science
Mayo Clinic Cancer Center
Phoenix, Arizona

Presenter
Rachna Shroff, MD, MS, FASCO
University of Arizona Cancer Center (UACC)
University of Arizona College of Medicine – Tucson (UA COM-T)
Tucson, Arizona